• Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us
Home
  • Biotech
    • Cell & Gene Therapy
    • Clinical Data
    • Venture Capital
    • Deals
  • Research
  • Medtech
    • Devices
    • Diagnostics
    • AI and Machine Learning
  • CRO
  • Special Reports
  • Trending
    • Biologics
    • Clinical Development
  • Fierce 50
    • Special Report
    • Awards Gala
  • Awards
    • CRO Awards
    • Innovation Awards
  • Resources
    • Fierce Events
    • Industry Events
    • Webinars
    • Podcasts
    • Whitepapers
    • Survey
  • Events
  • Subscribe
Home
Trending
Hamburger Menu Hamburger Menu
  • Biotech
    • Cell & Gene Therapy
    • Clinical Data
    • Venture Capital
    • Deals
  • Research
  • Medtech
    • Devices
    • Diagnostics
    • AI and Machine Learning
  • CRO
  • Special Reports
  • Trending
    • Biologics
    • Clinical Development
  • Fierce 50
    • Special Report
    • Awards Gala
  • Awards
    • CRO Awards
    • Innovation Awards
  • Resources
    • Fierce Events
    • Industry Events
    • Webinars
    • Podcasts
    • Whitepapers
    • Survey
  • Events
  • Subscribe
  • Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us

influenza vaccine

Monkey about to receive a vaccine
Research

AstraZeneca antibody protects monkeys from severe bird flu

Shown to ward off seasonal flu and bird flu in mice and ferrets, the antibody has now protected monkeys from getting severe H5N1 infections.
Darren Incorvaia Jan 30, 2025 2:00pm
bird flu avian flu

HHS gives Moderna $590M to 'accelerate' bird flu vaccine trials

Jan 21, 2025 8:24am
Novavax

FDA puts Novavax's phase 3 plan on hold for pair of vaccines

Oct 16, 2024 9:10am
flu virus b cells influenza

Pfizer, BioNTech combo mRNA shot latest to lose to flu strain B

Aug 16, 2024 8:25am
unlabeled vaccine

'Active' vaccine adjuvant boosts COVID, flu antibodies in mice

Jul 9, 2024 4:00am
change direction new plan alter arrows move reprioritize

CureVac gains $430M GSK vaccine contract, loses 30% of staff

Jul 3, 2024 5:00am

Home
  • Connect
    • The Team
    • Advertise
    • Marketing Kit
    • Let's Talk
  • Join Us
    • Newsletters
    • Resources
    • RSS Feeds
  • Our Brands
    • Fierce Pharma
    • Fierce Biotech
    • Fierce Healthcare
  • Our Events
    • Life Sciences Events
©2025 Questex LLC All rights reserved.
Terms of use
Privacy Policy
Privacy Settings